Pre-Exposure Prophylaxis product choice of participants in HPTN 083

AUTHORS

M.E. Clement1, Z. Wang2, C.J. Fichtenbaum3, S. Thomas4, J.A. Bazan5, P. Richardson6, M.A. Spinelli7, B. Hanscom2, A.R. Rinehart8, J.F. Rooney9, A. Adeyeye10, M. McCauley11, A. Jennings12, K. Gomez12, M. Cohen13, B. Grinsztejn14, R.J. Landovitz15, HPTN 083 Study Team


INSTITUTIONS

1Louisiana State University Health Sciences Center- New Orleans, Infectious Diseases, New Orleans, United States, 2Fred Hutchinson Cancer Research Center, Seattle, United States, 3University of Cincinnati, Division of Infectious Diseases, Cincinnati, United States, 4University of California Los Angeles, UCLA Vine Street Clinic, Los Angeles, United States, 5Ohio State University, Columbus, United States, 6Johns Hopkins University School of Medicine, Department of Pathology, Baltimore, United States, 7University of California San Francisco, San Francisco, United States, 8ViiV Healthcare, Research Triangle Park, United States, 9Gilead Sciences, Inc., Foster City, United States, 10U.S Centers for Disease Control and Prevention, Atlanta, United States, 11FHI 360, Washington DC, United States, 12FHI 360, Durham, United States, 13University of North Carolina Chapel Hill, Infectious Diseases, Chapel Hill, United States, 14Instituto Nacional de Infectologia Evandro Chagas-Fiocruz, Rio de Janeiro, Brazil, 15University of California Los Angeles, Los Angeles, United States
23 July 2024
English
Download e-poster

Presenter

Meredith E. Clement

Louisiana State University Health Sciences Center